Citius Oncology Announces Closing of $9.0 Million Registered Direct Offering and Concurrent Private Placement
CRANFORD, N.J., Sept. 10, 2025 /PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals,...